Report Company Directory
- SCI Engineered Materials, Inc. Reports Third Quarter and 2020 Year-to-Date Results by GlobeNewsWire
- SCI Engineered Materials, Inc. Reports Second Quarter and 2020 Year-to-Date Results by GlobeNewsWire
- SCI Engineered Materials, Inc. Reports First Quarter 2020 Results   by GlobeNewsWire
- SCI Engineered Materials, Inc. Reports 2019 Full-Year and Fourth Quarter Results by GlobeNewsWire
- SCI Engineered Materials, Inc. Reports 2019 Nine Month and Third Quarter Results by GlobeNewsWire
- SCI Engineered Materials, Inc. Reports 2019 Six Month and Second Quarter Results by GlobeNewsWire
- SCI Engineered Materials, Inc. To Present at Rocky Mountain Micro Cap Conference IV by GlobeNewsWire
- SCI Engineered Materials, Inc. Reports Improved First Quarter 2019 Results by GlobeNewsWire
- SCI Engineered Materials, Inc. Reports Record Twelve Month and Fourth Quarter 2018 Results by GlobeNewsWire
- SCI Engineered Materials, Inc. to Bond Thin Film Solar Products in China by GlobeNewsWire
- Five Directors sold after exercising options/sold 728,187 shares at 11.180USD. by SmartInsider
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017 by BusinessWire
- INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of SciClone Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information by BusinessWire
- INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of SciClone Pharmaceuticals Inc. to a Consortium is Fair to Shareholders by BusinessWire
- SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of SciClone Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information by BusinessWire
- SCICLONE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout by BusinessWire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of SciClone Pharmaceuticals Inc. to a Consortium is Fair to Shareholders – SCLN by BusinessWire